CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01846624
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:08.394910+00:00
Published At: 2018-09-07T00:00:00+00:00
Record Updated At: 2018-09-27
Results Posted At: 2018-09-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults", "AML (Adult) With 11q23 (MLL) Abnormalities", "AML (Adult) With Del (5q)", "AML (Adult) With Inv (16) (p13; q22)", "AML (Adult) With t (16;16) (p13; q22)", "AML (Adult) With t (8; 21) (q22; q22)", "Secondary AML (Adult)", "Untreated AML (Adult)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-27"
protocolSection.identificationModule.nctId: "NCT01846624"
protocolSection.identificationModule.officialTitle: "A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-09-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.